Genetically Determined Smoking Behavior and Risk of Nontraumatic Subarachnoid Hemorrhage
- PMID: 33440997
- PMCID: PMC7856108
- DOI: 10.1161/STROKEAHA.120.031622
Genetically Determined Smoking Behavior and Risk of Nontraumatic Subarachnoid Hemorrhage
Abstract
Background and purpose: Animal and observational studies indicate that smoking is a risk factor for aneurysm formation and rupture, leading to nontraumatic subarachnoid hemorrhage (SAH). However, a definitive causal relationship between smoking and the risk of SAH has not been established. Using Mendelian randomization (MR) analyses, we tested the hypothesis that smoking is causally linked to the risk of SAH.
Methods: We conducted a 1-sample MR study using data from the UK Biobank, a large cohort study that enrolled over 500 000 Britons aged 40 to 69 from 2006 to 2010. Participants of European descent were included. SAH cases were ascertained using a combination of self-reported, electronic medical record, and death registry data. As the instrument, we built a polygenic risk score using independent genetic variants known to associate (P<5×10-8) with smoking behavior. This polygenic risk score represents the genetic susceptibility to smoking initiation. The primary MR analysis utilized the ratio method. Secondary MR analyses included the inverse variance weighted and weighted median methods.
Results: A total of 408 609 study participants were evaluated (mean age, 57 [SD 8], female sex, 220 937 [54%]). Among these, 132 566 (32%) ever smoked regularly, and 904 (0.22%) had a SAH. Each additional SD of the smoking polygenic risk score was associated with 21% increased risk of smoking (odds ratio [OR], 1.21 [95% CI, 1.20-1.21]; P<0.001) and a 10% increased risk of SAH (OR, 1.10 [95% CI, 1.03-1.17]; P=0.006). In the primary MR analysis, genetic susceptibility to smoking was associated with a 63% increase in the risk of SAH (OR, 1.63 [95% CI, 1.15-2.31]; P=0.006). Secondary analyses using the inverse variance weighted method (OR, 1.57 [95% CI, 1.13-2.17]; P=0.007) and the weighted median method (OR, 1.74 [95% CI, 1.06-2.86]; P=0.03) yielded similar results. There was no significant pleiotropy (MR-Egger intercept P=0.39; MR Pleiotropy Residual Sum and Outlier global test P=0.69).
Conclusions: These findings provide evidence for a causal link between smoking and the risk of SAH.
Keywords: genetic variation; hemorrhagic stroke; intracranial aneurysm; subarachnoid hemorrhage.
Figures
Similar articles
-
Genetically proxied liability to migraine and risk of intracranial aneurysm and subarachnoid hemorrhage.Headache. 2025 Mar;65(3):391-398. doi: 10.1111/head.14851. Epub 2024 Nov 7. Headache. 2025. PMID: 39511824
-
Genetically determined blood pressure, antihypertensive medications, and risk of intracranial aneurysms and aneurysmal subarachnoid hemorrhage: A Mendelian randomization study.Eur Stroke J. 2024 Mar;9(1):244-250. doi: 10.1177/23969873231204420. Epub 2023 Oct 6. Eur Stroke J. 2024. PMID: 37800876 Free PMC article.
-
Genetic associations of sex hormones with cerebral aneurysm formation and subarachnoid hemorrhage: A two-sample Mendelian randomization analysis.J Clin Neurosci. 2025 Jun;136:111244. doi: 10.1016/j.jocn.2025.111244. Epub 2025 Apr 24. J Clin Neurosci. 2025. PMID: 40280082
-
Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population: A Systematic Review and Meta-analysis.JAMA Neurol. 2019 May 1;76(5):588-597. doi: 10.1001/jamaneurol.2019.0006. JAMA Neurol. 2019. PMID: 30659573 Free PMC article.
-
Evidence for causal effects of neuropsychiatric conditions on risk of venous thromboembolism: A univariable and multivariable Mendelian randomization study.J Vasc Surg Venous Lymphat Disord. 2024 Nov;12(6):101889. doi: 10.1016/j.jvsv.2024.101889. Epub 2024 Apr 15. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38621580 Free PMC article. Review.
Cited by
-
Exploring the causal links between cigarette smoking, alcohol consumption, and aneurysmal subarachnoid hemorrhage: a two-sample Mendelian randomization analysis.Front Nutr. 2024 Sep 13;11:1397776. doi: 10.3389/fnut.2024.1397776. eCollection 2024. Front Nutr. 2024. PMID: 39346642 Free PMC article.
-
Mendelian Randomization in Stroke: A Powerful Approach to Causal Inference and Drug Target Validation.Front Genet. 2021 Aug 12;12:683082. doi: 10.3389/fgene.2021.683082. eCollection 2021. Front Genet. 2021. PMID: 34456968 Free PMC article. Review.
-
Risk Factors of Aneurysmal Subarachnoid Hemorrhage Including Analysis by Sex: A Systematic Review and Meta-Analysis.Neurology. 2025 Apr 22;104(8):e213511. doi: 10.1212/WNL.0000000000213511. Epub 2025 Mar 28. Neurology. 2025. PMID: 40153684 Free PMC article.
-
Aneurysmal Subarachnoid Hemorrhage and Sex Differences: Analysis of Epidemiology, Outcomes, and Risk Factors.Neurocrit Care. 2024 Aug;41(1):119-128. doi: 10.1007/s12028-023-01929-5. Epub 2024 Jan 22. Neurocrit Care. 2024. PMID: 38253923
-
A two-sample Mendelian randomization analysis of modifiable risk factors and intracranial aneurysms.Sci Rep. 2022 May 10;12(1):7659. doi: 10.1038/s41598-022-11720-9. Sci Rep. 2022. PMID: 35538134 Free PMC article.
References
-
- Bonita R Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: A population-based case-control study. Stroke. 1986;17:831–835. - PubMed
-
- Juvela S, Hillbom M, Numminen H, Koskinen P. Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 1993;24:639–646. - PubMed
-
- Müller TB, Vik A, Romundstad PR, Sandvei MS. Risk factors for unruptured intracranial aneurysms and subarachnoid hemorrhage in a prospective population-based study. Stroke. 2019;50:2952–2955. - PubMed
-
- Lindbohm JV, Kaprio J, Jousilahti P, Salomaa V, Korja M. Sex, Smoking, and Risk for Subarachnoid Hemorrhage. Stroke. 2016;47:1975–1981. - PubMed
Publication types
MeSH terms
Grants and funding
- U24 NS107136/NS/NINDS NIH HHS/United States
- K76 AG059992/AG/NIA NIH HHS/United States
- P30 AG021342/AG/NIA NIH HHS/United States
- R03 NS112859/NS/NINDS NIH HHS/United States
- U24 NS107215/NS/NINDS NIH HHS/United States
- U01 NS106513/NS/NINDS NIH HHS/United States
- R01 NS110721/NS/NINDS NIH HHS/United States
- MC_PC_17228/MRC_/Medical Research Council/United Kingdom
- K07 AG043587/AG/NIA NIH HHS/United States
- R01 NR018335/NR/NINR NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- MC_QA137853/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials